Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald S Swerdloff

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Nature Clinical Practice. Urology|March 5, 2008
Should hypogonadal men who are suboptimally responsive to testosterone gel switch to another gel preparation?Ronald S Swerdloff
Clinical Endocrinology|February 19, 2014
Comments on 'low serum sex hormone binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients'Christina Wang, Ronald S Swerdloff
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Should the nonaromatizable androgen dihydrotestosterone be considered as an alternative to testosterone in the treatment of the andropause?Christina Wang, Ronald S Swerdloff
Annals of Internal Medicine|November 17, 2010
Dihydrotestosterone: hormone or autocrine--paracrine signal?Ronald S Swerdloff, Christina Wang
Current Opinion in Urology|September 3, 2010
Hormonal approaches to male contraceptionChristina Wang, Ronald S Swerdloff
Fertility and Sterility|December 3, 2014
Limitations of semen analysis as a test of male fertility and anticipated needs from newer testsChristina Wang, Ronald S Swerdloff
Endocrinology and Metabolism Clinics of North America|February 26, 2022
Testosterone Replacement Therapy in Hypogonadal MenChristina Wang, Ronald S Swerdloff
Expert Opinion on Emerging Drugs|August 24, 2016
Emerging medication for the treatment of male hypogonadismAydogan Aydogdu, Ronald S Swerdloff
Best Practice & Research. Clinical Obstetrics & Gynaecology|June 4, 2002
Male contraceptionChristina Wang, Ronald S Swerdloff
Best Practice & Research. Clinical Endocrinology & Metabolism|July 21, 2004
Androgens and the ageing maleRonald S Swerdloff, Christina Wang
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Nature Clinical Practice. Urology|March 5, 2008
Should hypogonadal men who are suboptimally responsive to testosterone gel switch to another gel preparation?Ronald S Swerdloff
Clinical Endocrinology|February 19, 2014
Comments on 'low serum sex hormone binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients'Christina Wang, Ronald S Swerdloff
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Should the nonaromatizable androgen dihydrotestosterone be considered as an alternative to testosterone in the treatment of the andropause?Christina Wang, Ronald S Swerdloff
Annals of Internal Medicine|November 17, 2010
Dihydrotestosterone: hormone or autocrine--paracrine signal?Ronald S Swerdloff, Christina Wang
Current Opinion in Urology|September 3, 2010
Hormonal approaches to male contraceptionChristina Wang, Ronald S Swerdloff
Fertility and Sterility|December 3, 2014
Limitations of semen analysis as a test of male fertility and anticipated needs from newer testsChristina Wang, Ronald S Swerdloff
Endocrinology and Metabolism Clinics of North America|February 26, 2022
Testosterone Replacement Therapy in Hypogonadal MenChristina Wang, Ronald S Swerdloff
Expert Opinion on Emerging Drugs|August 24, 2016
Emerging medication for the treatment of male hypogonadismAydogan Aydogdu, Ronald S Swerdloff
Best Practice & Research. Clinical Obstetrics & Gynaecology|June 4, 2002
Male contraceptionChristina Wang, Ronald S Swerdloff
Best Practice & Research. Clinical Endocrinology & Metabolism|July 21, 2004
Androgens and the ageing maleRonald S Swerdloff, Christina Wang
Pageof 15